Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Probable cause of EGS identified
Equines suffering from mild EGS can sometimes be treated with nursing and supportive care.
Discovery of neurotoxin could lead to new treatments.

Researchers from across several organisations have collaborated to identify a neurotoxin as the probable cause of equine grass sickness (EGS).

It is hoped that the discovery of this neurotoxin could lead to better diagnostics and novel treatments which would improve outcomes for the disease.

EGS is recognised by a rapid degeneration of a horse’s nerves, which leads to the paralysis of the gastrointestinal tract, an inability to swallow, abdominal pain and more.

There is no effective treatment for the most severe cases of the disease, and so many horses are euthanised on humane grounds. Some mild forms can be treated with nursing and supportive care.

The researchers believe that a neurotoxic enzyme, called phospholipase A2, may be responsible for EGS. The neurotoxin has similar actions to snake venom toxins, however it is produced by pasture microbes.

Electron microscopy was used to identify major abnormalities in affected horses, which researchers say represent a toxin-specific signature for the neurotoxin. These abnormalities were identified in horses’ neuromuscular junctions – microscopic communication sites between nerves and muscles which are crucial for normal muscle function.

Neurotoxic phospholipase A2 toxins are also present in the venom of poisonous snakes and, consequently, similarities have been drawn between signs of EGS and snake envenomation. Although there is currently no suggestion that snakes are causing EGS, it is hoped that the same drugs used to treat nerve regeneration in people paralysed by snake bites could be used to treat EGS.

The neurotoxin has now also been linked to animal dysautonomias, which contradicts previous theories which suggested EGS was a form of botulism.

Now that the toxin has been identified, there is work underway to confirm its source.

Currently, it is considered to be the result of a bacterium or fungus that grows in horses’ pastures. It normally grows in cold and dry weather, which usually precedes an outbreak of the disease.

The discovery was the result of work from several organisations: the Dick Vet Equine Hospital at the University of Edinburgh, Newcastle University, Istituto Zooprofilattico Sperimentale delle Venezie and the University of Padova.

Bruce McGorum, of the Royal (Dick) School of Veterinary Studies, said: “Identifying a probable cause of Equine Grass Sickness represents a significant breakthrough. We hope that this discovery will lead to novel treatments and improved diagnostics for this devastating condition.

“We are very grateful for the generous support we have received from horse owners, veterinary surgeons, scientists, charities and funding bodies.”

The full study can be read here.

Image © Equine Veterinary Journal

Become a member or log in to add this story to your CPD history

Survey launched to investigate EHV

News Story 1
 Zoetis has launched a new survey to identify management techniques for Equine Herpes Virus (EHV).

EHV is a contagious, airborne virus that can cause respiratory problems and severe diseases in horses and ponies. It spreads among horses over short distances, direct contact and through shared equipment.

The survey will explore current knowledge and management practices with EHV in the UK. It is quick to complete and participants could win one of 10 equine first aid kits.

Complete the survey here

Click here for more...
News Shorts
WSAVA launches pet travel guidance factsheet

A new pet travel guidance factsheet for veterinary professionals and caregivers has been developed by the WSAVA in collaboration with the World Veterinary Association.

The Dog and Cat Welfare During Transport factsheet provides step-by-step guidance for all stages of a journey, from pre-travel checklists to post-travel care.

Brachycephalic breeds or animals prone to travel-related anxiety are given special focus in this guide, which also provides links to IATA container regulation and WSAVA vaccination guidelines.